MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
3.140
+0.050
+1.62%
After Hours: 3.140 0 0.00% 17:43 02/06 EST
OPEN
3.170
PREV CLOSE
3.090
HIGH
3.210
LOW
3.070
VOLUME
1.13M
TURNOVER
--
52 WEEK HIGH
5.10
52 WEEK LOW
1.665
MARKET CAP
802.92M
P/E (TTM)
-3.7195
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MRVI last week (0126-0130)?
Weekly Report · 5d ago
Maravai LifeSciences Holdings (NASDAQ:MRVI shareholders incur further losses as stock declines 11% this week, taking five-year losses to 90%
Simply Wall St · 01/29 10:47
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Maravai Lifesciences Holdings (MRVI)
TipRanks · 01/29 08:40
Weekly Report: what happened at MRVI last week (0119-0123)?
Weekly Report · 01/26 09:24
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX)
TipRanks · 01/23 14:40
Weekly Report: what happened at MRVI last week (0112-0116)?
Weekly Report · 01/19 09:26
Weekly Report: what happened at MRVI last week (0105-0109)?
Weekly Report · 01/12 09:25
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders
Simply Wall St · 01/06 12:11
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.